Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study

<p>Abstract</p> <p>Background</p> <p>Traditional peripheral biofeedback has grade A evidence for effectively treating migraines. Two newer forms of neurobiofeedback, EEG biofeedback and hemoencephalography biofeedback were combined with thermal handwarming biofeedback t...

Full description

Bibliographic Details
Main Authors: Lappin Martha S, Stokes Deborah A
Format: Article
Language:English
Published: BMC 2010-02-01
Series:Behavioral and Brain Functions
Online Access:http://www.behavioralandbrainfunctions.com/content/6/1/9
id doaj-8f8f1992da7d4d64925e1517319c6ace
record_format Article
spelling doaj-8f8f1992da7d4d64925e1517319c6ace2020-11-24T21:53:27ZengBMCBehavioral and Brain Functions1744-90812010-02-0161910.1186/1744-9081-6-9Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome studyLappin Martha SStokes Deborah A<p>Abstract</p> <p>Background</p> <p>Traditional peripheral biofeedback has grade A evidence for effectively treating migraines. Two newer forms of neurobiofeedback, EEG biofeedback and hemoencephalography biofeedback were combined with thermal handwarming biofeedback to treat 37 migraineurs in a clinical outpatient setting.</p> <p>Methods</p> <p>37 migraine patients underwent an average of 40 neurofeedback sessions combined with thermal biofeedback in an outpatient biofeedback clinic. All patients were on at least one type of medication for migraine; preventive, abortive or rescue. Patients kept daily headache diaries a minimum of two weeks prior to treatment and throughout treatment showing symptom frequency, severity, duration and medications used. Treatments were conducted an average of three times weekly over an average span of 6 months. Headache diaries were examined after treatment and a formal interview was conducted. After an average of 14.5 months following treatment, a formal interview was conducted in order to ascertain duration of treatment effects.</p> <p>Results</p> <p>Of the 37 migraine patients treated, 26 patients or 70% experienced at least a 50% reduction in the frequency of their headaches which was sustained on average 14.5 months after treatments were discontinued.</p> <p>Conclusions</p> <p>All combined neuro and biofeedback interventions were effective in reducing the frequency of migraines with clients using medication resulting in a more favorable outcome (70% experiencing at least a 50% reduction in headaches) than just medications alone (50% experience a 50% reduction) and that the effect size of our study involving three different types of biofeedback for migraine (1.09) was more robust than effect size of combined studies on thermal biofeedback alone for migraine (.5). These non-invasive interventions may show promise for treating treatment-refractory migraine and for preventing the progression from episodic to chronic migraine.</p> http://www.behavioralandbrainfunctions.com/content/6/1/9
collection DOAJ
language English
format Article
sources DOAJ
author Lappin Martha S
Stokes Deborah A
spellingShingle Lappin Martha S
Stokes Deborah A
Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study
Behavioral and Brain Functions
author_facet Lappin Martha S
Stokes Deborah A
author_sort Lappin Martha S
title Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study
title_short Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study
title_full Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study
title_fullStr Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study
title_full_unstemmed Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study
title_sort neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study
publisher BMC
series Behavioral and Brain Functions
issn 1744-9081
publishDate 2010-02-01
description <p>Abstract</p> <p>Background</p> <p>Traditional peripheral biofeedback has grade A evidence for effectively treating migraines. Two newer forms of neurobiofeedback, EEG biofeedback and hemoencephalography biofeedback were combined with thermal handwarming biofeedback to treat 37 migraineurs in a clinical outpatient setting.</p> <p>Methods</p> <p>37 migraine patients underwent an average of 40 neurofeedback sessions combined with thermal biofeedback in an outpatient biofeedback clinic. All patients were on at least one type of medication for migraine; preventive, abortive or rescue. Patients kept daily headache diaries a minimum of two weeks prior to treatment and throughout treatment showing symptom frequency, severity, duration and medications used. Treatments were conducted an average of three times weekly over an average span of 6 months. Headache diaries were examined after treatment and a formal interview was conducted. After an average of 14.5 months following treatment, a formal interview was conducted in order to ascertain duration of treatment effects.</p> <p>Results</p> <p>Of the 37 migraine patients treated, 26 patients or 70% experienced at least a 50% reduction in the frequency of their headaches which was sustained on average 14.5 months after treatments were discontinued.</p> <p>Conclusions</p> <p>All combined neuro and biofeedback interventions were effective in reducing the frequency of migraines with clients using medication resulting in a more favorable outcome (70% experiencing at least a 50% reduction in headaches) than just medications alone (50% experience a 50% reduction) and that the effect size of our study involving three different types of biofeedback for migraine (1.09) was more robust than effect size of combined studies on thermal biofeedback alone for migraine (.5). These non-invasive interventions may show promise for treating treatment-refractory migraine and for preventing the progression from episodic to chronic migraine.</p>
url http://www.behavioralandbrainfunctions.com/content/6/1/9
work_keys_str_mv AT lappinmarthas neurofeedbackandbiofeedbackwith37migraineursaclinicaloutcomestudy
AT stokesdeboraha neurofeedbackandbiofeedbackwith37migraineursaclinicaloutcomestudy
_version_ 1725872186164510720